Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px
Document › Details

Medigene AG. (5/4/17). "Press Release: Medigene Announces Capital Increase of New Shares [NOT FOR DISTRIBUTION, PUBLICATION OR FORWARDING IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA]". Planegg.

Organisations Organisation Medigene AG (FSE: MDG1, Prime Standard)
  Group Medigene (Group)
  Organisation 2 INSTITUTIONAL INVESTORS
Products Product T cell therapy
  Product 2 investment banking
Index term Index term Medigene–SEVERAL: investment, 201705 private placement €20.7m 1.965m new shares at €10.55/share to institutional investors
Person Person Schendel, Dolores J. (Medigene 201602– CEO before CMO before Trianta Immunotherapies + HelmholtzZentrum München)
     


   
Record changed: 2017-05-07

Advertisement

Picture [iito] – Putting Information into Context 600x102px

More documents for Medigene (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px




» top